Your shopping cart is currently empty

Synonyms: NSC 9222

| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 1 mg | $68 | In Stock | In Stock | |
| 5 mg | $163 | In Stock | In Stock | |
| 10 mg | $243 | In Stock | In Stock | |
| 25 mg | $397 | In Stock | In Stock | |
| 50 mg | Preferential | In Stock | In Stock |
| Description | Robinin (NSC-9222) belongs to natural products, serving as a TLR2 inhibitor with cell permeability. Robinin exerts anti-inflammatory and antitumor activities through inhibiting the TLR2-PI3K-AKT pathway, and can be used for experimental research related to pancreatic cancer. |
| Targets & IC50 | A549 cells viability:34.49 μM |
| In vitro | Methods: Mouse primary chondrocytes were used. After 12 h treatment with IL-1β (10 ng/mL) to establish an injury model, cells were incubated with 10 μg/mL Robinin for 24 h. Results: CCK-8 and flow cytometry showed that Robinin reversed the IL-1β-induced decrease in cell viability and inhibited apoptosis; Western blot further confirmed its protective effects by upregulating Bcl-2 and downregulating Bax and cleaved-caspase3 expression. [1] Methods: H9c2 rat cardiomyocytes were used. Cells were pre-treated with 50 μM Robinin for 24 h, followed by addition of 40 μM H₂O₂ or 5 μM doxorubicin to induce injury. Results: MTT, AO/EB, and Hoechst staining showed that Robinin increased cell viability and reduced apoptosis; DCFH-DA and flow cytometry demonstrated its reduction of reactive oxygen species levels, enhancement of antioxidant enzyme activity, and inhibition of endoplasmic reticulum stress-related gene and protein expression. [2] |
| In vivo | Methods: In a hypercholesterolemic rat model, 2% cholesterol diet was used to induce hypercholesterolemia for 8 weeks. Starting from week 6, Robinin (50 mg/kg, once every two days, dissolved in DMSO; control received vehicle) was administered by intraperitoneal injection for 2 consecutive weeks, followed by ex vivo cardiac ischemia-reperfusion injury. Results: Robinin improved cardiac function, inhibited mitochondrial permeability transition pore opening, attenuated myocardial histopathological damage, upregulated myocardial Akt, Nrf2, HO-1, and NQO1 expression, and downregulated GSK3β and Fyn levels.[3] |
| Synonyms | NSC 9222 |
| Molecular Weight | 740.66 |
| Formula | C33H40O19 |
| Cas No. | 301-19-9 |
| Smiles | C[C@@H]1O[C@@H](OC[C@H]2O[C@@H](Oc3c(oc4cc(O[C@@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@H]5O)cc(O)c4c3=O)-c3ccc(O)cc3)[C@H](O)[C@@H](O)[C@H]2O)[C@H](O)[C@H](O)[C@H]1O |
| Relative Density. | 1.74 g/cm3 |
| Storage | Keep away from moisture Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | Pyridine, Methanol, etc.: Soluble Ethanol: Soluble DMSO: 100 mg/mL (135.01 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+40% PEG300+5% Tween-80+45% Saline: 3.3 mg/mL (4.46 mM), Sonication is recommended. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
Note : The dilution table applies only to solid products. For liquid products, please calculate the stock solution based on the stated concentration and/or density. | ||||||||||||||||||||||||||||||||||||
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.